Ekso Bionics Holdings Inc
0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS
Case Summary | |
Company Name: | Ekso Bionics Holdings Inc |
Stock Symbol : | NASDAQ: EKSO |
Class Period Start: | 03/15/2017 |
Class Period End: | 12/27/2017 |
Lead Plaintiff motion: | 03/05/2018 |
Date Filed: | 01/02/2018 |
Type of Case: | Securities Class Action |
Court: | U.S. District Court for the Eastern District of New York |
Summary: | Thieler Law Corp advises investors with losses exceeding $100,000 of the March 5, 2018 lead plaintiff deadline in a class action lawsuit filed against Ekso Bionics Holdings Inc (NASDAQ: EKSO) (“Ekso” or “the Company”). The suit is pending in the U.S. District Court for the Eastern District of New York and investors, who purchased Ekso Bionics Holdings Inc securities between March 15, 2017 and December 27, 2017, have until March 5, 2018 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class. If you purchased Ekso Bionics Holdings Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class. The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that there was a material weakness in Ekso’s internal control over financial reporting and Ekso’s disclosure controls and procedures were not effective; and as a result, Defendants’ public statements were materially false and misleading at all relevant times. On December 14, 2017, the Company disclosed that it suffered from material weaknesses to its internal controls over disclosure and that it would be required to amend its Form 10-K for the 2016 fiscal year and its Forms 10-Q for the first three quarters of 2017. On this news, NASDAQ: EKSO fell $0.15, or 6.17%, to close at $2.28 on December 15, 2017. If you were negatively impacted by your investment in Ekso Bionics Holdings Inc securities between March 15, 2017 and December 27, 2017 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation. Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Thieler Law Corp 2534 State Street - Suite 406, San Diego, CA 92101 by email: mail@thielerlaw.com or telephone at +1 (619) 377 - 4324 or visit our website http://www.thielerlaw.com/ or Facsimile: +1 (619) 785 – 3185 |